Company Filing History:
Years Active: 2025
Title: Paul Stabach: Innovator in ENPP1 Polypeptides
Introduction
Paul Stabach is a notable inventor based in Woodbridge, CT (US). He has made significant contributions to the field of biotechnology, particularly through his work on ENPP1 polypeptides. His innovative approach has led to advancements that may have important implications in medical applications.
Latest Patents
Stabach holds a patent for "ENPP1 polypeptides and methods of using same." This invention includes ENPP1 polypeptides with improved in vivo half-lives. Additionally, it provides an ENPP1 polypeptide fusion that comprises an ENPP1 polypeptide fused to a Fc region of an immunoglobulin, wherein the polypeptide fusion includes at least one point mutation. This patent showcases his expertise in enhancing the functionality of polypeptides for therapeutic uses.
Career Highlights
Paul Stabach is affiliated with Yale University, where he continues to engage in research and development. His work at this prestigious institution has allowed him to collaborate with other leading scientists and contribute to groundbreaking research in his field.
Collaborations
One of his notable collaborators is Demetrios Braddock. Their partnership exemplifies the collaborative spirit of innovation in research, although further details on their joint projects are not available.
Conclusion
Paul Stabach's contributions to the field of biotechnology, particularly through his patent on ENPP1 polypeptides, highlight his role as an innovator. His work at Yale University and collaborations with other researchers further emphasize his commitment to advancing scientific knowledge.